Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?
We report two patients who had been initially diagnosed as having a myelodysplastic syndrome but subsequently progressed into a leukothrombocytosis state which mimicked a chronic myeloproliferative disorder. Both patients had anemia and mild neutropenia without thrombocytopenia at the time of their diagnosis of myelodysplastic syndrome, and dyshematopoietic features were present in the bone marrow. After treatment with vitamin D3 for 7 and 18 months, respectively, they developed leukothrombocytosis which responded to hydroxyurea. We speculate that these and other similar patients with this unusual course might constitute an entity distinct from the typical myelodysplastic syndromes or chronic myeloproliferative disorders.
Ohyashiki
K
K
First Department of Internal Medicine, Tokyo Medical College, Japan.
Yokoyama
K
K
Kimura
Y
Y
Ohyashiki
J H
JH
Ito
T
T
Kuratsuji
T
T
Komatsumoto
S
S
Nara
M
M
Toyama
K
K
D000368:Aged; D000748:Anemia, Macrocytic / Q000097:blood / Q000188:drug therapy / Q000473:pathology*; D000753:Anemia, Refractory / Q000097:blood / Q000188:drug therapy / Q000473:pathology*; D000754:Anemia, Refractory, with Excess of Blasts / Q000097:blood / Q000188:drug therapy / Q000473:pathology*; D001853:Bone Marrow / Q000473:pathology*; D003937:Diagnosis, Differential; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000097:blood / Q000473:pathology*; D010976:Platelet Count
D006918:Hydroxyurea